Quantum Rally Lifts IonQ to New Highs, Even as $2 Billion Federal Fund Passes It By

IonQ jumps on quantum sector rally from US CHIPS Act grants, but receives no direct subsidies. Stock trades above average analyst target, with extreme valuation and insider selling concerns.

IonQ's stock charged higher Thursday, closing at $70.10 with a 7.2% gain, as the broader quantum-computing sector caught fire from a massive US government spending package. But the irony hasn't been lost on traders: IonQ itself didn't receive a single dollar of the new subsidies.

The CHIPS Act grant, totaling $2.013 billion, is being distributed among nine quantum-technology firms. The biggest winner is IBM, which gets $1 billion for its "Anderson" foundry. D-Wave, Rigetti, and Infleqtion are each in line for up to $100 million. IonQ’s name is absent from the list. Yet investors are betting that the sheer scale of federal support will lift the entire industry — and IonQ along with it.

Trading volume hit 31.49 million shares, roughly 19% above the daily average, pushing IonQ’s market cap to about $26.17 billion. Some of that enthusiasm is mechanical: short sellers have been caught offside. The short interest in the GraniteShares 2x Long IONQ Daily ETF collapsed by 83.2% in mid-May to just 28,319 shares, suggesting forced covering is adding fuel to the rally.

Technically, the stock has become stretched. It now trades 30.2% above its 20-day moving average of $52.79 and 44.5% above the 200-day line of $47.57. The Relative Strength Index sits at 70.69, firmly in overbought territory. Chart-watchers are eyeing resistance at $76.00, while near-term support is seen around $60.00. That kind of gap often triggers a volatility spike.

Valuation metrics paint an even more extreme picture. IonQ’s price-to-sales ratio has climbed to 109. For context, the commonly cited threshold for sustainable high-growth valuations is around 30, and the sector average is just 4.16. That’s a disconnect that has some analysts cautious, even as the growth narrative remains intact.

On the fundamental side, IonQ delivered first-quarter 2026 revenue of $64.67 million — a staggering 754.7% year-over-year surge. The bottom line, however, remains in the red: a loss per share of $0.34, wider than the analyst consensus of $0.26. Management responded by lifting the full-year guidance to between $260 million and $270 million, up from the prior range of $225 million to $245 million.

The order backlog, measured as remaining performance obligations, stands at $470 million. And the recently closed acquisition of SkyWater Technology in May 2026 bolsters IonQ’s in-house manufacturing and scaling capabilities. That vertical-integration strategy is a key differentiator versus peers that are receiving government money to build foundries.

Wall Street remains broadly constructive. The analyst consensus is a "Moderate Buy," with 10 buy ratings, 6 holds, and 1 sell. The average price target is $68.63, with individual estimates reaching as high as $100.00. But the stock already trades above the average target, leaving limited upside from current levels.

One persistent concern is insider selling. Over the past five years, IonQ insiders have sold $576 million worth of stock while buying just $3.35 million. Across the quantum sector — including Rigetti and D-Wave — net insider sales total $931 million. That pattern is hard to ignore when the stock is priced for perfection.

For now, the market is betting on momentum and sector-wide validation from Washington. Whether IonQ can deliver on its raised revenue forecast and turn its backlog into cash will determine if the current rally has legs — or if the zone around $76.00 becomes a ceiling.